Simulations Plus, Inc. (SLP)
NASDAQ • Technology
Last close at September 10, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Simulations Plus, Inc. keeps $16 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 29
in 48 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About Simulations Plus, Inc.
Simulations Plus, Inc. (NASDAQ: SLP) develops scientific software for drug and molecular modeling, serving the life-sciences and regulated-product markets as an application software company. In FY2025, revenue was $79.2 million. Its platform combines simulation, quantitative pharmacology, and predictive chemistry tools used across research, development, and regulatory work.
Today's Snapshot
So far today, SLP is trading slightly higher at 18.42, while its sector was firmer.
Trading Volume
Below 10d avg (182.9K)
56.9K
vs S&P 500 Today
Underperforming Market
-0.93%
Updated: September 11, 2026 at 19:04 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$16.85 - $18.42Buy
- RSI (14)62.70Neutral
- Stochastic %K (14, 3, 3)54.91Neutral
- MACD Level (12, 26)0.05Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.